These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

817 related items for PubMed ID: 27745954

  • 1. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague.
    Arnaboldi PM, Sambir M, D'Arco C, Peters LA, Seegers JF, Mayer L, McCormick AA, Dattwyler RJ.
    Vaccine; 2016 Nov 11; 34(47):5768-5776. PubMed ID: 27745954
    [Abstract] [Full Text] [Related]

  • 2. Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    D'Arco C, McCormick AA, Arnaboldi PM.
    Vaccine; 2021 Mar 01; 39(9):1435-1444. PubMed ID: 33531196
    [Abstract] [Full Text] [Related]

  • 3. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
    Kilgore PB, Sha J, Hendrix EK, Motin VL, Chopra AK.
    mBio; 2021 Dec 21; 12(6):e0322321. PubMed ID: 34872353
    [Abstract] [Full Text] [Related]

  • 4. Delivery of Yersinia pestis antigens via Escherichia coli outer membrane vesicles offered improved protection against plague.
    Tong Z, Zhang X, Guo X, Wu G, Cao S, Zhang Y, Meng X, Wang T, Wang Y, Song Y, Yang R, Du Z.
    mSphere; 2024 Sep 25; 9(9):e0033024. PubMed ID: 39158304
    [Abstract] [Full Text] [Related]

  • 5. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague.
    Sanapala S, Rahav H, Patel H, Sun W, Curtiss R.
    Vaccine; 2016 May 05; 34(21):2410-2416. PubMed ID: 27060051
    [Abstract] [Full Text] [Related]

  • 6. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
    Sha J, Kirtley ML, Klages C, Erova TE, Telepnev M, Ponnusamy D, Fitts EC, Baze WB, Sivasubramani SK, Lawrence WS, Patrikeev I, Peel JE, Andersson JA, Kozlova EV, Tiner BL, Peterson JW, McWilliams D, Patel S, Rothe E, Motin VL, Chopra AK.
    Clin Vaccine Immunol; 2016 Jul 05; 23(7):586-600. PubMed ID: 27170642
    [Abstract] [Full Text] [Related]

  • 7. Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation.
    Zhang W, Song X, Zhai L, Guo J, Zheng X, Zhang L, Lv M, Hu L, Zhou D, Xiong X, Yang W.
    Front Immunol; 2022 Jul 05; 13():793382. PubMed ID: 35154110
    [Abstract] [Full Text] [Related]

  • 8. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS, Wulff CR, Garvy BA, Straley SC.
    Adv Exp Med Biol; 2007 Jul 05; 603():400-14. PubMed ID: 17966436
    [Abstract] [Full Text] [Related]

  • 9. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A, Hanada Y, Khalifé M, Carniel E, Demeure CE.
    PLoS Negl Trop Dis; 2015 Jul 05; 9(10):e0004162. PubMed ID: 26473734
    [Abstract] [Full Text] [Related]

  • 10. LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.
    Sun W, Sanapala S, Henderson JC, Sam S, Olinzock J, Trent MS, Curtiss R.
    Infect Immun; 2014 Oct 05; 82(10):4390-404. PubMed ID: 25114109
    [Abstract] [Full Text] [Related]

  • 11. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague.
    Chichester JA, Musiychuk K, Farrance CE, Mett V, Lyons J, Mett V, Yusibov V.
    Vaccine; 2009 May 26; 27(25-26):3471-4. PubMed ID: 19200825
    [Abstract] [Full Text] [Related]

  • 12. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
    Williamson ED, Packer PJ, Waters EL, Simpson AJ, Dyer D, Hartings J, Twenhafel N, Pitt ML.
    Vaccine; 2011 Jun 24; 29(29-30):4771-7. PubMed ID: 21570437
    [Abstract] [Full Text] [Related]

  • 13. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.
    Lin JS, Park S, Adamovicz JJ, Hill J, Bliska JB, Cote CK, Perlin DS, Amemiya K, Smiley ST.
    Vaccine; 2010 Dec 16; 29(2):357-62. PubMed ID: 20840834
    [Abstract] [Full Text] [Related]

  • 14. A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.
    Galen JE, Wang JY, Carrasco JA, Lloyd SA, Mellado-Sanchez G, Diaz-McNair J, Franco O, Buskirk AD, Nataro JP, Pasetti MF.
    Infect Immun; 2015 Jan 16; 83(1):161-72. PubMed ID: 25332120
    [Abstract] [Full Text] [Related]

  • 15. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.
    Bowen W, Batra L, Pulsifer AR, Yolcu ES, Lawrenz MB, Shirwan H.
    Vaccine; 2019 Sep 10; 37(38):5708-5716. PubMed ID: 31416643
    [Abstract] [Full Text] [Related]

  • 16. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.
    Do Y, Koh H, Park CG, Dudziak D, Seo P, Mehandru S, Choi JH, Cheong C, Park S, Perlin DS, Powell BS, Steinman RM.
    Eur J Immunol; 2010 Oct 10; 40(10):2791-6. PubMed ID: 20812236
    [Abstract] [Full Text] [Related]

  • 17. A Recombinant Attenuated Yersinia pseudotuberculosis Vaccine Delivering a Y. pestis YopENt138-LcrV Fusion Elicits Broad Protection against Plague and Yersiniosis in Mice.
    Singh AK, Curtiss R, Sun W.
    Infect Immun; 2019 Oct 10; 87(10):. PubMed ID: 31331960
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.
    Erova TE, Rosenzweig JA, Sha J, Suarez G, Sierra JC, Kirtley ML, van Lier CJ, Telepnev MV, Motin VL, Chopra AK.
    Clin Vaccine Immunol; 2013 Feb 10; 20(2):227-38. PubMed ID: 23239803
    [Abstract] [Full Text] [Related]

  • 19. Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.
    Quenee LE, Ciletti NA, Elli D, Hermanas TM, Schneewind O.
    Vaccine; 2011 Sep 02; 29(38):6572-83. PubMed ID: 21763383
    [Abstract] [Full Text] [Related]

  • 20. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague.
    Branger CG, Fetherston JD, Perry RD, Curtiss R.
    Adv Exp Med Biol; 2007 Sep 02; 603():387-99. PubMed ID: 17966435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.